Impact of delaying botulinum toxin treatment in patients with migraine during the COVID-19 pandemic

Henrique Nascimento; Gonçalo Videira; Sara Duarte; Carlos Correia; Carlos Andrade

doi:10.1055/s-0043-1763490

Arquivos de Neuro-Psiquiatria (Mar 2023)

Impact of delaying botulinum toxin treatment in patients with migraine during the COVID-19 pandemic

Henrique Nascimento,
Gonçalo Videira,
Sara Duarte,
Carlos Correia,
Carlos Andrade

Affiliations

Henrique Nascimento: ORCiD; Centro Hospitalar Universitário do Porto, Hospital de Santo António, Serviço de Neurologia, Porto, Portugal.
Gonçalo Videira: ORCiD; Centro Hospitalar Universitário do Porto, Hospital de Santo António, Serviço de Neurologia, Porto, Portugal.
Sara Duarte: ORCiD; Centro Hospitalar Universitário do Porto, Hospital de Santo António, Serviço de Neurologia, Porto, Portugal.
Carlos Correia: ORCiD; Centro Hospitalar Universitário do Porto, Hospital de Santo António, Serviço de Neurologia, Porto, Portugal.
Carlos Andrade: ORCiD; Centro Hospitalar Universitário do Porto, Hospital de Santo António, Serviço de Neurologia, Porto, Portugal.

DOI: https://doi.org/10.1055/s-0043-1763490
Journal volume & issue: Vol. 81, no. 03
pp. 248 – 252

Abstract

Read online

Background Due to coronavirus disease 2019 (COVID-19) pandemic response measures, the administration of botulinum toxin (BTX) was delayed for many patients during the first lockdown period in Portugal.

Published in Arquivos de Neuro-Psiquiatria

ISSN: 0004-282X (Print); 1678-4227 (Online)
Publisher: Academia Brasileira de Neurologia (ABNEURO)
Country of publisher: Brazil
LCC subjects: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
Website: https://www.scielo.br/j/anp/

About the journal

Abstract

Keywords